Insights

Generics Expansion Leverage Impax-Amneal combined scale in U.S. generics to target expansion in high-demand therapeutic areas and legacy brands, offering a broader portfolio to healthcare providers and distributors seeking cost-efficient generic options.

R&D and Manufacturing Growth capitalize on recent facility expansions and the Kashiv acquisition to pursue partnerships or contract manufacturing opportunities, especially in new NJ and Illinois sites, enabling quicker time-to-market for complex generics and biosimilars.

Oncology Pipeline Highlight the FDA-approved lanreotide launch as a proof point to engage oncology channels, explore co-promotion or out-licensing arrangements, and upsell specialized injectable therapies to hospital networks and specialty pharmacies.

Accessible Pricing Position the combined entity as a cost-effective alternative for healthcare systems and payers, offering bundled generic and branded opportunities, with a focus on affordability and improving patient access to essential medicines.

Strategic Partnerships Target collaborations with hospitals, clinics, and distributors for turnkey sourcing, inventory optimization, and school/emergency health programs leveraging Amneal’s distribution footprint and Impax’s generics strength to win new contracts.

Similar companies to Impax Laboratories

Impax Laboratories Tech Stack

Impax Laboratories uses 8 technology products and services including LinkedIn Ads, iCIMS, Microsoft SharePoint, and more. Explore Impax Laboratories's tech stack below.

Media & News

Impax Laboratories's Email Address Formats

Impax Laboratories uses at least 7 email formats:
Impax Laboratories Email FormatsExamplePercentage
FLast@impaxlabs.comJDoe@impaxlabs.com
79%
First.Last@impaxlabs.comJohn.Doe@impaxlabs.com
20%
FirstLast@impaxlabs.comJohnDoe@impaxlabs.com
1%
First.Last@amneal.comJohn.Doe@amneal.com
56%
FLast@amneal.comJDoe@amneal.com
24%
FirstL@amneal.comJohnD@amneal.com
13%
First@amneal.comJohn@amneal.com
7%

Frequently Asked Questions

What is Impax Laboratories's phone number?

Minus sign iconPlus sign icon
You can contact Impax Laboratories's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Impax Laboratories's stock symbol?

Minus sign iconPlus sign icon
Impax Laboratories is a publicly traded company; the company's stock symbol is IPXL.

What is Impax Laboratories's official website and social media links?

Minus sign iconPlus sign icon
Impax Laboratories's official website is amneal.com and has social profiles on LinkedIn.

How much revenue does Impax Laboratories generate?

Minus sign iconPlus sign icon
As of October 2026, Impax Laboratories's annual revenue is estimated to be $250M - $500M.

What is Impax Laboratories's SIC code and NAICS code?

Minus sign iconPlus sign icon
Impax Laboratories's SIC code is 8071 - Medical Laboratories and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Impax Laboratories have currently?

Minus sign iconPlus sign icon
As of October 2026, Impax Laboratories has approximately 348 employees across 2 continents, including North America and Europe. Key team members include Chief Financial Officer: A. K., Chief Compliance Officer: D. P. and Vice President Regulatory Affairs And Compliance: M. M. Explore Impax Laboratories's employee directory with LeadIQ.

What industry does Impax Laboratories belong to?

Minus sign iconPlus sign icon
Impax Laboratories operates in the Pharmaceutical Manufacturing industry.

What technology does Impax Laboratories use?

Minus sign iconPlus sign icon
Impax Laboratories's tech stack includes LinkedIn Ads, iCIMS, Microsoft SharePoint, Magento, Articulate Storyline, VMware vCenter, Adobe Creative Suite and Webex.

What is Impax Laboratories's email format?

Minus sign iconPlus sign icon
Impax Laboratories's email format typically follows the pattern of FLast@impaxlabs.com. Find more Impax Laboratories email formats with LeadIQ.

When was Impax Laboratories founded?

Minus sign iconPlus sign icon
Impax Laboratories was founded in 1999.
Impax Laboratories logo

Impax Laboratories

Pharmaceutical ManufacturingCalifornia, United States201-500 Employees

Amneal Pharmaceuticals, Inc., formed by the merger of Impax Laboratories and Amneal Pharmaceuticals LLC, operates in pharmaceutical manufacturing with a focus on generics and a growing branded portfolio. The company is based in Hayward, California, and trades on the New York Stock Exchange under the ticker AMRX. 
Its customers include healthcare providers and patients seeking affordable medicines, reflecting its position in the U.S. generics and branded pharmaceutical space. Recent news notes the U.S. FDA approval of romidepsin injection solution.

Section iconCompany Overview

Phone number
Website
amneal.com
SIC Code
8071 - Medical Laboratories
Stock Symbol
IPXL
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1999
Employees
201-500

Section iconFunding & Financials

  • $250M - $500M

    Impax Laboratories's revenue is estimated to be in the range of $250M - $500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.